Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)

De qué trata este estudio

El registro indica que este estudio recluta participantes. La disponibilidad puede variar por centro.

Tipo de estudio

De intervención

Fase

No aplica

Rango de edad

18 años - No especificado

Sexo admitido

Todos los sexos

Voluntarios sanos

Aceptados

Participantes

1319 Estimado

Estos son puntos de partida, no una decisión de elegibilidad. El equipo debe revisar todos los requisitos.

Acerca de la investigación

The purpose of this study is to determine the most effective family-centered intervention (FCI) for weight loss and obesity prevention in Hispanic families. FCI is a type of program that involves family (such as parents and caregivers) supporting their children to promote healthy habits.

¿Quién podría participar?

La lista siguiente contiene el texto del patrocinador. Puede incluir condiciones, tratamientos previos, resultados de pruebas y otros requisitos. Aparecer en tu búsqueda no significa que califiques.

Inclusion Criteria:

Phase 1

• Age \>= 18 years (per self-report)
• Self-identifies as Hispanic/Latino (per self-report)
• Seeking, or has used, services at the VDS or MHU (per self-report)
• Is the parent or primary caregiver for at least one child aged 8-12 living in their household (per self-report)
• Screens as obese (BMI \> 30 kg/m2) or overweight (BMI of 25 - 29.9 kg/m2) (per height and weight measurement in person or per self-report)
• Owns a cell phone capable of receiving text messages (per self-report)
• Owns an internet connected device (e.g. cell phone, tablet, etc.) capable of conducting videoconference calls (per self-report)
• Agrees to be audio-recorded (per self-report)

Phase 2 (parent participants)

• Age \>= 18 years (per self-report)
• Self-identifies as Hispanic/Latino (per self-report)
• Seeking, or has used, services at the VDS or MHU (per self-report)
• Is the parent or primary caregiver for at least one child aged 8-12 living in their household (per self-report)
• Screens as obese (BMI \> 30 kg/m2) or overweight (BMI of 25 - 29.9 kg/m2) (per height and weight measurement in person or remotely)
• Owns a cell phone capable of receiving text messages (per self-report)
• Owns an internet connected device (e.g. cell phone, tablet, etc.) capable of conducting videoconference calls (per self-report)
• Agrees to be audio-recorded (per self-report)

Phase 2 (child participants)

• Age 8-12 years (per parent self-report)
• Has a parent or primary caregiver who is eligible and participating in Phase 2 (per parent self-report)

Exclusion Criteria:

Phase 1

• Is pregnant or might be pregnant (per self-report)
• Presence of a chronic disease such as cancer, kidney disease, liver disease, etc. (individuals with hypertension and diabetes mellitus may still participate) that may affect diet and study participation (per self-report)
• Has dietary restrictions, i.e. liquid diet, that may affect diet and study participation (per self-report)
• Has a household member who has already participated or agreed to participate in this study program (per self-report)
• Prior participation in one of our preliminary studies, e.g., COMIDA, SANOS, Family COMIDA (per self-report) and any related focus groups
• Works for or with the VDS or MHU (per self-report)
• Presence of cognitive impairment disorder (i.e., delirium or dementia) sufficient to preclude meaningful informed consent and/or data collection (per study team)

Phase 2 (parent participant)

• Is pregnant or might be pregnant (per self-report)
• For women, is lactating (per self-report)
• Presence of a chronic disease such as cancer, kidney disease, liver disease, etc. (individuals with hypertension and diabetes mellitus may still participate) that may affect diet and study participation (per self-report)
• Has dietary restrictions, i.e., liquid diet, that may affect diet and study participation (per self-report)
• Has physical activity restrictions, i.e., handicapped or mobility issues, that may affect physical activity participation (increasing step counts; per self-report)
• Has a household member who has already participated or agreed to participate in this study program (per self-report)
• Prior participation in one of our preliminary studies, e.g., COMIDA, SANOS, Family COMIDA (per self-report) and any related focus groups
• Works for or with the VDS or MHU (per self-report)
• Presence of cognitive impairment disorder (i.e., delirium or dementia) sufficient to preclude meaningful informed consent and/or data collection (per study team)
• Has been prescribed Ozempic, Wegovy, Mounjaro, Rybelsus, Trulicity (or other GLP 1 receptor agonist), or any other drug to treat obesity (per self-report) or (if previously prescribed) 7 weeks have not passed since the last dose was taken.
• Has undergone weight loss/bariatric surgery (RYBG, gastric banding, sleeve gastrectomy, balloon, etc.) or is planning to undergo such surgery in the next 12 months (per self-report)

Phase 2 (child participant)

• Has dietary restrictions, i.e., liquid diet, that may affect diet and study participation (per parent self-report)
• Has physical activity restrictions, i.e., handicapped or mobility issues, that may affect physical activity participation (per parent self-report)
• Has an eating disorder (per parent self-report)
• Is underweight (per parent self-report)

Tratamiento, grupos y participación

El registro puede describir tratamientos y duración sin incluir un calendario completo. Pide al equipo las visitas, procedimientos, riesgos, costos y alternativas. Mantén tu atención habitual salvo que tu médico te indique un cambio.

Asignación

Asignación al azar

Enmascaramiento

Sin enmascaramiento

Qué evalúan los investigadores

Estas medidas indican qué se estudia. No prueban que un tratamiento funcione.

Medidas principales

Centros de investigación (1)

El estado general puede diferir del estado de un centro. Confirma la disponibilidad antes de trasladarte.

1 centros

Equipo y fechas

Patrocinador principal

Memorial Sloan Kettering Cancer Center

Inicio del estudio

26 ago 2025 Real

Finalización primaria

31 jul 2029 Estimado

Finalización del estudio

31 jul 2029 Estimado

Primera publicación

28 ago 2025 Real

Última actualización

10 nov 2026 Real

Contactos oficiales del estudio